Mental health platform Headspace launched a new feature last week called Ebb, an empathetic AI companion, to help people process their emotions. Santa Monica, California-based Headspace offers an ...

Big data analysis is an invaluable resource in healthcare and life sciences. Data can tell a pharmaceutical company which drugs a medical specialist prescribes and where they are based. This ...

Suki, a company offering AI voice solutions to healthcare companies, has secured $70 million in Series D funding, it announced Thursday. The financing will help the company build new products.

Yet another Bay Area healthcare AI startup was born this week. On Tuesday, San Francisco-based generative AI voice platform Parakeet Health formally launched and announced $3 million in seed funding.

Parenting in today’s fast-paced, social media-driven world continually presents new challenges, especially when it comes to children’s mental health and wellness. A recent Surgeon General ...

The conundrum of American health care has become all too familiar: While spending outpaces other high-income countries, our quality of care often lags our peers – demonstrating no real ...

The healthcare industry is on the cusp of a transformation similar to that witnessed by the banking industry 15 to 20 years ago. Like healthcare, banking is a very personal yet highly regulated ...

The 2024 election is nearing the corner and has major implications for the healthcare industry, from abortion to drug pricing. During the Reuters Total Health Conference held in Chicago on Tuesday ...

A MeiraGTx Holdings gene therapy for Parkinson’s disease has preliminary data from a small clinical trial showing the one-time treatment showed both safety and efficacy, results that lay the ...

Bipartisan Congressional scrutiny has shone a harsh spotlight on the many tactics used by pharmacy benefit managers (PBMs) and Big Pharma that contribute to the sky high costs of prescription ...

Shortly after releasing a scathing interim report in July that revealed how three players dominate the pharmacy benefit manager market and raise drug costs for patients, the Federal Trade ...

Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company whose lead asset is in late-stage clinical ...